62 related articles for article (PubMed ID: 12356606)
1. Complementary and alternative medicine use among men with prostate cancer in 4 ethnic populations.
Lee MM; Chang JS; Jacobs B; Wrensch MR
Am J Public Health; 2002 Oct; 92(10):1606-9. PubMed ID: 12356606
[No Abstract] [Full Text] [Related]
2. Race/ethnicity and the perception of the risk of developing prostate cancer.
Shavers VL; Underwood W; Moser RP
Am J Prev Med; 2009 Jul; 37(1):64-7. PubMed ID: 19423272
[TBL] [Abstract][Full Text] [Related]
3. Commentary--anatomy of racial disparity in influenza vaccination.
Fiscella K
Health Serv Res; 2005 Apr; 40(2):539-49. PubMed ID: 15762906
[No Abstract] [Full Text] [Related]
4. Older adults' self-management of daily symptoms: complementary therapies, self-care, and medical care.
Arcury TA; Grzywacz JG; Neiberg RH; Lang W; Nguyen H; Altizer K; Stoller EP; Bell RA; Quandt SA
J Aging Health; 2012 Jun; 24(4):569-97. PubMed ID: 22187091
[TBL] [Abstract][Full Text] [Related]
5. Exploring Integrative Approaches: Insights Into Complementary Medicine Practices Among Breast Cancer Survivors in Saudi Arabia.
Abusanad A; Ujaimi R; Alotaibi MA; Alharbi LA; Alatawi N; Algarni AA; Samkari A
Cureus; 2024 Jan; 16(1):e52282. PubMed ID: 38357079
[TBL] [Abstract][Full Text] [Related]
6. Advances in Molecular Regulation of Prostate Cancer Cells by Top Natural Products of Malaysia.
Prieto JM; Hanafi MMM
Curr Issues Mol Biol; 2023 Feb; 45(2):1536-1567. PubMed ID: 36826044
[TBL] [Abstract][Full Text] [Related]
7. The use of complementary and alternative medicine by patients with cancer: a cross-sectional survey in Saudi Arabia.
Abuelgasim KA; Alsharhan Y; Alenzi T; Alhazzani A; Ali YZ; Jazieh AR
BMC Complement Altern Med; 2018 Mar; 18(1):88. PubMed ID: 29530034
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with the use of complementary and alternative medicines for prostate cancer by long-term survivors.
Egger S; Hughes S; Smith DP; Chambers S; Kahn C; Moxey A; O'Connell DL
PLoS One; 2018; 13(3):e0193686. PubMed ID: 29513724
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms and therapeutic effectiveness of pulsed electromagnetic field therapy in oncology.
Vadalà M; Morales-Medina JC; Vallelunga A; Palmieri B; Laurino C; Iannitti T
Cancer Med; 2016 Nov; 5(11):3128-3139. PubMed ID: 27748048
[TBL] [Abstract][Full Text] [Related]
10. The Janus-Faced Role of Antioxidants in Cancer Cachexia: New Insights on the Established Concepts.
Assi M; Rébillard A
Oxid Med Cell Longev; 2016; 2016():9579868. PubMed ID: 27642498
[TBL] [Abstract][Full Text] [Related]
11. Quality of Life and Patterns of Use of Complementary and Alternative Medicines Among Glioma Patients.
Mobed K; Liu R; Stewart S; Wrensch M; McCoy L; Rice T; Prados M; Chang S
J Support Oncol; 2009; 7(6):W23-W31. PubMed ID: 26692824
[TBL] [Abstract][Full Text] [Related]
12. Complementary and alternative therapies for urinary symptoms: use in a diverse population sample qualitative study.
Jackson CB; Taubenberger SP; Botelho E; Joseph J; Tennstedt SL
Urol Nurs; 2012; 32(3):149-57. PubMed ID: 22860393
[TBL] [Abstract][Full Text] [Related]
13. Use of complementary medications among older adults with cancer.
Maggiore RJ; Gross CP; Togawa K; Tew WP; Mohile SG; Owusu C; Klepin HD; Lichtman SM; Gajra A; Ramani R; Katheria V; Klapper SM; Hansen K; Hurria A;
Cancer; 2012 Oct; 118(19):4815-23. PubMed ID: 22359348
[TBL] [Abstract][Full Text] [Related]
14. Use of Chinese medicine by cancer patients: a review of surveys.
Carmady B; Smith CA
Chin Med; 2011 Jun; 6():22. PubMed ID: 21651825
[TBL] [Abstract][Full Text] [Related]
15. Complementary and alternative medicine use among newly diagnosed prostate cancer patients.
McDermott CL; Blough DK; Fedorenko CR; Arora NK; Zeliadt SB; Fairweather ME; Oakley-Girvan I; Van Den Eeden SK; Ramsey SD
Support Care Cancer; 2012 Jan; 20(1):65-73. PubMed ID: 21120540
[TBL] [Abstract][Full Text] [Related]
16. Use of complementary and alternative medicine for treatment among African-Americans: a multivariate analysis.
Barner JC; Bohman TM; Brown CM; Richards KM
Res Social Adm Pharm; 2010 Sep; 6(3):196-208. PubMed ID: 20813333
[TBL] [Abstract][Full Text] [Related]
17. Polypharmacy in older adults with cancer.
Maggiore RJ; Gross CP; Hurria A
Oncologist; 2010; 15(5):507-22. PubMed ID: 20418534
[TBL] [Abstract][Full Text] [Related]
18. A multivariate test of an expanded Andersen Health Care utilization model for complementary and alternative medicine (CAM) use in African Americans.
Brown C; Barner J; Bohman T; Richards K
J Altern Complement Med; 2009 Aug; 15(8):911-9. PubMed ID: 19678783
[TBL] [Abstract][Full Text] [Related]
19. Prostate tumor growth can be modulated by dietarily targeting the 15-lipoxygenase-1 and cyclooxygenase-2 enzymes.
Kelavkar UP; Hutzley J; McHugh K; Allen KG; Parwani A
Neoplasia; 2009 Jul; 11(7):692-9. PubMed ID: 19568414
[TBL] [Abstract][Full Text] [Related]
20. Nutraceuticals in Prostate Disease: The Urologist's Role.
Curtis Nickel J; Shoskes D; Roehrborn CG; Moyad M
Rev Urol; 2008; 10(3):192-206. PubMed ID: 18836556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
